Growth Metrics

Astria Therapeutics (ATXS) Other Non-Current Assets: 2017-2018

Historic Other Non-Current Assets for Astria Therapeutics (ATXS) over the last 2 years, with Dec 2018 value amounting to $254,000.

  • Astria Therapeutics' Other Non-Current Assets rose 26.55% to $143,000 in Q3 2019 from the same period last year, while for Sep 2019 it was $143,000, marking a year-over-year increase of 26.55%. This contributed to the annual value of $254,000 for FY2018, which is 124.78% up from last year.
  • Latest data reveals that Astria Therapeutics reported Other Non-Current Assets of $254,000 as of FY2018, which was up 124.78% from $113,000 recorded in FY2017.
  • Astria Therapeutics' Other Non-Current Assets' 5-year high stood at $254,000 during FY2018, with a 5-year trough of $113,000 in FY2017.
  • Moreover, its 2-year median value for Other Non-Current Assets was $183,500 (2017), whereas its average is $183,500.
  • Data for Astria Therapeutics' Other Non-Current Assets shows a peak YoY spiked of 124.78% (in 2018) over the last 5 years.
  • Astria Therapeutics' Other Non-Current Assets (Yearly) stood at $113,000 in 2017, then skyrocketed by 124.78% to $254,000 in 2018.